$DRNK $SNNC NOHO, INC. PROVIDES OPERATIONS UPDATE AND FORECAST FOR 2022
https://www.globenewswire.com/news-release/20...-2022.html
Scottsdale, Arizona, Dec. 02, 2021 (GLOBE NEWSWIRE) -- NOHO, Inc. (OTC PINK: DRNK), a Wyoming corporation (the “Company”), announced the following:
Our Company has seen an amazing resurgence in 2021. In a mere eight months, we have brought the financial reporting current, reduced the debt, engaged a top-tier branding agency, developed a new product and created a fully functioning direct to consumer website with new products on the way. And we haven’t even started yet!
The Company has successfully reduced a majority of its total debt in 2021, extinguishing approximately one million dollars of derivative liabilities. Additional debt reduction has continued in Q4.
The After Shot is available on our revamped site created by Eric Stoll and Lifetime Branding. While available for sale across the country, the formal launch of the site will happen in Q1 2022 behind a broad-based marketing campaign including targeting consumers online and through social media.
The Company is proud to announce a product development agreement with Las Vegas-based gaming influencer, D Lucky. On Instagram as DLuckySlots, he commands an audience of 4.1M followers and growing, focused on strategies to gain advantages in playing casino slot machines. As described on the corporate site:
D LUCKY is regarded as one of the most elite slot machine players in the world after setting numerous records for consistent payouts in Casino Slot Play. Now D LUCKY brings his knowledge and expertise to the public, so anyone who is interested in playing slot machines can do so with the inside tips and strategies from the most successful slot machine player in the world.
In addition to the After Shot, new products have already been formulated and packaging design is completed. The first addition to the line will be a nootropics shot, an all-natural formulation designed to provide focus. The Company is seeking to add at least three new products to the NOHO line throughout 2022.
In June of this year, NOHO acquired the RāD8 brand from Sibannac, Inc. (OTC Pink: SNNC), which was created initially around Delta-8 THC. Following a recent reversal from its initial position, the DEA has said that the popular cannabinoid falls under the purview of the 2018 Farm Bill and should be treated as CBD. There are many opportunities for consumer and white-label manufacturing sales that the Company will be pursuing into next year. Currently, the Company can manufacture Delta-8 gummies and vape cartridges in its Scottsdale-based manufacturing facility now shared with Sibannac.
Delta-8 THC is a hemp-based cannabinoid derived from compliant hemp under the 2018 Farm Bill. Delta 8, while a THC derivative, does not fall under the Controlled Substances Act as Marijuana, as long as it is derived from hemp containing less than .3% Delta-9 THC.
The Company will also be executing an awareness campaign beginning in the new year that will feature digital ads as well as physical billboard placement, in addition to interviews with the management team. For new investors, please see our last shareholder call: Event recording.
More from NOHO – in addition to the After Shot, we have developed a new line of products, all leveraging Hydro-Nano technology, which will be rolling out soon. For additional information and product updates, please follow us at www.nohoshot.com and follow NOHO on Twitter at www.twitter.com/nohodrink.
https://www.globenewswire.com/news-release/20...-2022.html
Scottsdale, Arizona, Dec. 02, 2021 (GLOBE NEWSWIRE) -- NOHO, Inc. (OTC PINK: DRNK), a Wyoming corporation (the “Company”), announced the following:
Our Company has seen an amazing resurgence in 2021. In a mere eight months, we have brought the financial reporting current, reduced the debt, engaged a top-tier branding agency, developed a new product and created a fully functioning direct to consumer website with new products on the way. And we haven’t even started yet!
The Company has successfully reduced a majority of its total debt in 2021, extinguishing approximately one million dollars of derivative liabilities. Additional debt reduction has continued in Q4.
The After Shot is available on our revamped site created by Eric Stoll and Lifetime Branding. While available for sale across the country, the formal launch of the site will happen in Q1 2022 behind a broad-based marketing campaign including targeting consumers online and through social media.
The Company is proud to announce a product development agreement with Las Vegas-based gaming influencer, D Lucky. On Instagram as DLuckySlots, he commands an audience of 4.1M followers and growing, focused on strategies to gain advantages in playing casino slot machines. As described on the corporate site:
D LUCKY is regarded as one of the most elite slot machine players in the world after setting numerous records for consistent payouts in Casino Slot Play. Now D LUCKY brings his knowledge and expertise to the public, so anyone who is interested in playing slot machines can do so with the inside tips and strategies from the most successful slot machine player in the world.
In addition to the After Shot, new products have already been formulated and packaging design is completed. The first addition to the line will be a nootropics shot, an all-natural formulation designed to provide focus. The Company is seeking to add at least three new products to the NOHO line throughout 2022.
In June of this year, NOHO acquired the RāD8 brand from Sibannac, Inc. (OTC Pink: SNNC), which was created initially around Delta-8 THC. Following a recent reversal from its initial position, the DEA has said that the popular cannabinoid falls under the purview of the 2018 Farm Bill and should be treated as CBD. There are many opportunities for consumer and white-label manufacturing sales that the Company will be pursuing into next year. Currently, the Company can manufacture Delta-8 gummies and vape cartridges in its Scottsdale-based manufacturing facility now shared with Sibannac.
Delta-8 THC is a hemp-based cannabinoid derived from compliant hemp under the 2018 Farm Bill. Delta 8, while a THC derivative, does not fall under the Controlled Substances Act as Marijuana, as long as it is derived from hemp containing less than .3% Delta-9 THC.
The Company will also be executing an awareness campaign beginning in the new year that will feature digital ads as well as physical billboard placement, in addition to interviews with the management team. For new investors, please see our last shareholder call: Event recording.
More from NOHO – in addition to the After Shot, we have developed a new line of products, all leveraging Hydro-Nano technology, which will be rolling out soon. For additional information and product updates, please follow us at www.nohoshot.com and follow NOHO on Twitter at www.twitter.com/nohodrink.
